<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-29T20:11:42+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020 ESMO Asia | CDK4/6抑制剂探索HR+乳腺癌辅助治疗，monarchE研究能否改变临床实践？</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/FChKcvnu61YO9lYzj2gwig</id>
    <link href="https://mp.weixin.qq.com/s/FChKcvnu61YO9lYzj2gwig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>徐波教授：明确发展目标，积极谋划智能肿瘤学学科发展</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/p8H9wYsb_3HgBv1JtjjH-A</id>
    <link href="https://mp.weixin.qq.com/s/p8H9wYsb_3HgBv1JtjjH-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020第一届肺癌多学科申城论坛】韩宝惠教授专访：抗血管生成治疗在晚期NSCLC治疗中的非凡意义</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/_BPETpgNiE-H2ahp4TyMvQ</id>
    <link href="https://mp.weixin.qq.com/s/_BPETpgNiE-H2ahp4TyMvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 ESMO Asia丨Futibatinib 用于伴FGFR2融合/重排的肝内胆管癌，前景可观</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/u8HEjQTlAXeGz9oGBOi3Yg</id>
    <link href="https://mp.weixin.qq.com/s/u8HEjQTlAXeGz9oGBOi3Yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【JCO】ARTSCAN Ⅲ：顺铂联合放疗对比西妥昔单抗联合放疗于局部晚期头颈部鳞状细胞癌患者有更好的疗效</title>
    <updated>2020-11-29T19:13:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/1lyDvRwe8PVZ2gKqI6eOdA</id>
    <link href="https://mp.weixin.qq.com/s/1lyDvRwe8PVZ2gKqI6eOdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO Asia 2020】KRAS：不可成药的靶点是否已被攻克？</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/lQ0fQ9ITpPNvSuWo1cFLZA</id>
    <link href="https://mp.weixin.qq.com/s/lQ0fQ9ITpPNvSuWo1cFLZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO ASIA】林榕波教授团队氢吗啡酮PCA（患者自控镇痛技术）静脉滴定治疗重度癌痛更新研究成果！</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/anA9_VOfCc2dOlQTal7_tA</id>
    <link href="https://mp.weixin.qq.com/s/anA9_VOfCc2dOlQTal7_tA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020第一届肺癌多学科申城论坛】王佳蕾教授：十五年风雨兼程，多学科综合协作理念与机制“双轨并行”</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/9Z4fWUnb7TIyyyZz8Otc1A</id>
    <link href="https://mp.weixin.qq.com/s/9Z4fWUnb7TIyyyZz8Otc1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO Asia 2020】洞悉真实世界MET基因异常晚期NSCLC的临床特征及治疗现状</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/Nt9oi78hniApfCeS7KNiJg</id>
    <link href="https://mp.weixin.qq.com/s/Nt9oi78hniApfCeS7KNiJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【会议预告】中国消化道肿瘤免疫治疗学术论坛-2020 POST ESMO (11月29日)</title>
    <updated>2020-11-28T18:49:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/1o7h9JKiZBO0R7GLMO_ozQ</id>
    <link href="https://mp.weixin.qq.com/s/1o7h9JKiZBO0R7GLMO_ozQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>周琦教授：子宫肉瘤备受关注，影像新技术或可破解诊疗困境</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/TtIX8aZzfqJpicWcKsu7OA</id>
    <link href="https://mp.weixin.qq.com/s/TtIX8aZzfqJpicWcKsu7OA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陆舜教授分享EGFR克隆性前瞻性研究成果，分子克隆影响靶向治疗疗效</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/P1LRDhaZjJC8JUJF6TI43Q</id>
    <link href="https://mp.weixin.qq.com/s/P1LRDhaZjJC8JUJF6TI43Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020第一届肺癌多学科申城论坛】陈海泉教授：关注影像随访，注重全程管理，磨玻璃结节无需闻之色变</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/Yv1hhVCX3Dnuh5v84WHw-Q</id>
    <link href="https://mp.weixin.qq.com/s/Yv1hhVCX3Dnuh5v84WHw-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【ESMO Asia 2020】阿法替尼挑战EGFR非经典突变型NSCLC，亚裔/非亚裔患者这几类非经典突变疗效显著</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/IqW9VHGJHODfTNtkb-WXiA</id>
    <link href="https://mp.weixin.qq.com/s/IqW9VHGJHODfTNtkb-WXiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【超级训练营】20天，从实际案例系统学习临床试验前沿设计方法！开始报名啦！</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/B0M0YjS6ST0zGTw2xxK6Ow</id>
    <link href="https://mp.weixin.qq.com/s/B0M0YjS6ST0zGTw2xxK6Ow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>会议动态 | 2020年中原乳腺论坛日程抢先看！</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/VAlo7K3N5A2AD4_FVfhcCw</id>
    <link href="https://mp.weixin.qq.com/s/VAlo7K3N5A2AD4_FVfhcCw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【上新啦】胃癌肝转移、肺转移患者还有根治的机会吗？</title>
    <updated>2020-11-27T19:28:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/JbiHBL-DQe3HnP89xVWb0g</id>
    <link href="https://mp.weixin.qq.com/s/JbiHBL-DQe3HnP89xVWb0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“GIST 新时空”专栏 |张鹏副教授公开课：2020 CTOS胃肠间质瘤研究进展</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/d208PAE-LNXTtLpjw29G8w</id>
    <link href="https://mp.weixin.qq.com/s/d208PAE-LNXTtLpjw29G8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>六聚钱江弦歌不辍，精准诊疗再续篇章</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Sf6WcShq0Xh0iz2B_N0Q3g</id>
    <link href="https://mp.weixin.qq.com/s/Sf6WcShq0Xh0iz2B_N0Q3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>博学慎思，明辨笃行——2020年CACA肺癌靶向治疗专家研讨会郑州站</title>
    <updated>2020-11-26T18:52:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Xy2O--Km8lI8Z1SL3TOKHg</id>
    <link href="https://mp.weixin.qq.com/s/Xy2O--Km8lI8Z1SL3TOKHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>